New Developments in Pain Management
Monograph
Are you a Pharmacy Tech? Check out the Pharmacy Tech version of this course.
Course Summary
Pain is a universally understood sign of disease or injury, but it may also be considered a medical condition in its own right. The complexity associated with understanding or assessing pain makes its treatment challenging to the healthcare clinician. These difficulties can be serious when pain treatment gives rise to other health problems, such as medication tolerance or misuse. A newly approved oral drug, Seglentis, may offer an alternative pain management approach that addresses some of the challenges clinicians face when treating a patient’s pain. Future directions in pain management include new target-directed small-molecule analgesics, gene therapy, ligand-gated ion channels, anti-inflammatory cytokines, pain-modulating neurotransmitters, and image-guided delivery of locoregional pain syndromes.
Course Objectives
Provide an overview of pain types and characteristics
Describe pain modulation, assessment, and diagnosis
Describe pharmacological and non-pharmacological approaches to pain management
Discuss current challenges in pain management
Discuss the new co-crystal (celecoxib and tramadol hydrochloride) drug for use in acute pain management
I. Introduction
II. Defining Pain
III. Types of Pain
IV. Acute and Chronic Pain
V. Pain Modulation
VI. Pain Assessment
VII. Pain Diagnosis
VIII. Managing Pain
1. Pharmacological Pain Treatments
2. Non-pharmacologic Pain Treatments
3. Multidisciplinary Approach to Pain Management
IX. Challenges of Pain Management
1. Misuse and Dependence on Opioids
2. Challenges of Pain Management in Long-Term Care
X. Seglentis
XI. Future Trends
XII. Summary
- Read the course objectives and faculty planner disclosure
- Read the course material
- Complete the post-test with a minimum score of 70% and complete the course evaluation form.
- Results are automatically submitted to CPE Monitor
Faculty Planner Disclosure
The following individuals were involved in the development of this activity: Salam Kadhim, PhD, and Susan DePasquale, MSN, PMHNP-BC. There are no financial relationships relevant to this activity to report or disclose by any of the individuals involved in the development of this activity.
Unlabeled Use Disclosures
The information provided in this course is general in nature and it is solely designed to provide participants with continuing education credit(s). This course and materials are not meant to substitute for the independent, professional judgment of any participant regarding that participant’s professional practice, including but not limited to patient assessment, diagnosis, treatment and/or health management. Medical and pharmacy practices, rules, and laws vary from state to state, and this course does not cover the laws of each state; therefore, participants must consult the laws of their state as they relate to their professional practice. Healthcare professionals, including pharmacists and pharmacy technicians, must consult with their employer, healthcare facility, hospital, or other organization, for guidelines, protocols, and procedures they are to follow. The information provided in this course does not replace those guidelines, protocols, and procedures but is for academic purposes only, and this course’s limited purpose is for the completion of continuing education credits. Participants are advised and acknowledge that information related to medications, their administration, dosing, contraindications, adverse reactions, interactions, warnings, precautions, or accepted uses are constantly changing, and any person taking this course understands that such person must make an independent review of medication information prior to any patient assessment, diagnosis, treatment and/or health management. Any discussion of off-label use of any medication, device, or procedure is informational only and such uses are not endorsed hereby. Nothing contained in this course represents the opinions, views, judgments, or conclusions of RxCe.com LLC. RxCe.com LLC is not liable or responsible to any person for any inaccuracy, error, or omission with respect to this course, or course material.
Computer Hardware/Software Requirements
Please ensure the device you plan to use meets these requirements and specifications:
- Operating System: Windows 7,8,10, or 11 /Mac OS X 10.9 or later/iOS/Android
- Supported Browsers: Microsoft Edge, Firefox, Google Chrome, Safari, Opera
- A connection to the internet
- For Live Webinars or Conferences: GoToWebinar application for iOS, Android, Mac, or PC. You cannot 'call into' a live conference.
- Target Audience: Pharmacist
- Contact Hours: 1.0 (0.1 CEUs)
- Activity Release Date: 11/11/2022
- Activity Expiration Date: 11/11/2025
- Activity Type: Knowledge
- UAN: 0669-0000-22-064-H08-P
- Topic: Pain Management/Opioids
- CeBroker Number: 20-971124
Author:
RxCe.com, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.